We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Forge a Successful CRISPR Therapeutic Path With High-Quality GMP sgRNA

The rapid increase in CRISPR-mediated cell and gene therapies in clinical trials over the past few years is a testimony to the promising future of next-generation medicine.

While improved technological prowess empowers the development of more CRISPR-edited therapies, supply-chain and manufacturing hurdles still pose significant barriers to clinical and commercialization timelines.

Watch this webinar to learn more about:

  • The state of CRISPR cell and gene therapies
  • Challenges in CRISPR therapy manufacturing
  • A next-generation manufacturing facility